Octagam 5% Versus Comparator Post Marketing Trial
Public ClinicalTrials.gov record NCT01859754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Postmarketing Requirement Non-Interventional 2-armed Study to Evaluate the Safety of Octagam® Immune Globulin Intravenous (Human) 5% Liquid Preparation, With a Special Emphasis on Monitoring, Analysis and Reporting of Thromboembolic Events
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study Design: This is a 2 arm non-interventional trial that will compare the occurrence of adverse drug reactions between Octagam 5% and other marketed IVIG infusion treatments.
Study identification
- NCT ID
- NCT01859754
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 623 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2013 (Actual)
- Primary completion
- May 22, 2019 (Actual)
- Completion
- May 22, 2019 (Actual)
- Last update posted
- Jun 10, 2019
2013 – 2019
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Octapharma Research Site | Granada Hills | California | 91344 | — |
| Octapharma Research Site | Irvine | California | 92697 | — |
| Octapharma Research Site | Los Angeles | California | 90025 | — |
| Octapharma Research Site | Redlands | California | 92373 | — |
| Octapharma Research Site | Centennial | Colorado | 80112 | — |
| Octapharma Research Site | Roswell | Georgia | 30076 | — |
| Octapharma Research Site | Chicago | Illinois | 60612 | — |
| Octapharma Research Site | Springfield | Illinois | 62701 | — |
| Octapharma Research Site | Fort Wayne | Indiana | 46815 | — |
| Octapharma Research Site | Wichita | Kansas | 67201 | — |
| Octapharma Research Site | Fort Mitchell | Kentucky | 41017 | — |
| Octapharma Research Site | Farmington Hills | Michigan | 48334 | — |
| Octapharma Research Site | Plymouth | Minnesota | 55446 | — |
| Octapharma Research Site | Plymouth | Minnesota | 55447 | — |
| Octapharma Research Site | Omaha | Nebraska | 68124 | — |
| Octapharma Research Site | East Setauket | New York | 11733 | — |
| Octapharma Research Site | New York | New York | 10012 | — |
| Octapharma Research Site | New York | New York | 10065 | — |
| Octapharma Research Site | Columbus | Ohio | 43235 | — |
| Octapharma Research Site | Mayfield Heights | Ohio | 44124 | — |
| Octapharma Research Site | Toledo | Ohio | 43617 | — |
| Octapharma Research Site | Pawtucket | Rhode Island | 02860 | — |
| Octapharma Research Site | Anderson | South Carolina | 29621 | — |
| Octapharma Research Site | Nashville | Tennessee | 37203 | — |
| Octapharma Research Site | Amarillo | Texas | 79124 | — |
| Octapharma Research Site | Dallas | Texas | 75231 | — |
| Octapharma Research Site | Irving | Texas | 75014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01859754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2019 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01859754 live on ClinicalTrials.gov.